Original Research
Published on 02 Dec 2022
Combined treatment by burosumab and a calcimimetic can ameliorate hypophosphatemia due to excessive actions of FGF23 and PTH in adult XLH with tertiary hyperparathyroidism: A case report
in Bone Research
- 4,771 views
- 5 citations